LP
COGT icon

LMR Partners’s Cogent Biosciences COGT Stock Holding History

LMR Partners’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.94M Sell
50,000
-5,389
-10% -$189K 0.01% 905
2026
Q1 		$2.13M Buy
55,389
+956
+2% +$35.3K ﹤0.01% 842
2025
Q4 		$1.93M Buy
+54,433
New +$1.53M ﹤0.01% 823
2024
Q4 		– Sell
-44,483
Closed -$480K – 1269
2024
Q3 		$480K Buy
+44,483
New +$433K ﹤0.01% 841
2021
Q2 		– Sell
-35,009
Closed -$307K – 1155
2021
Q1 		$307K Buy
+35,009
New +$337K 0.01% 727

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

LMR Partners's COGT Position: Q2 2026 in Review

LMR Partners reduced its Cogent Biosciences (COGT) stake by 9.7% in Q2 2026, selling an estimated $189K and leaving 50,000 shares worth $1.94M. The position accounts for 0.01% of the portfolio, ranked #905.

LMR Partners first reported a position in COGT in Q1 2021 and has held it in 5 quarters since. The position peaked at $2.13M in Q1 2026. 324 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • LMR Partners held 50,000 shares of Cogent Biosciences worth $1.94M as of Q2 2026.
  • LMR Partners sold 5,389 Cogent Biosciences shares in Q2 2026, an estimated $189K.
  • Cogent Biosciences made up 0.01% of LMR Partners's portfolio in Q2 2026, its #905 holding.
  • LMR Partners first reported a position in Cogent Biosciences in Q1 2021 and has held it in 5 quarters since.
  • LMR Partners's Cogent Biosciences position peaked at $2.13M in Q1 2026.
  • 324 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.